Yüklüyor......
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening
OBJECTIVES: The Prostate Cancer Prevention Trial (PCPT) prostate cancer risk calculator was developed to aid physicians in counseling men for consideration of prostate biopsy based on prostate-specific antigen (PSA) and other clinical risk factors. This study investigated the role of body mass index...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2975830/ https://ncbi.nlm.nih.gov/pubmed/20739049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2010.04.060 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|